-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIMMUNE RECEIVES FDA BREAKTHROUGH THERAPY DESIGNATION FOR PEMVIDUTIDE IN MASH

路透·01/05/2026 12:30:00

登錄查看新聞詳情